Synopsys, Inc. $SNPS Shares Acquired by Jacobs & Co. CA

Jacobs & Co. CA increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 11.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 27,411 shares of the semiconductor company’s stock after purchasing an additional 2,844 shares during the period. Synopsys accounts for approximately 1.2% of Jacobs & Co. CA’s investment portfolio, making the stock its 27th biggest position. Jacobs & Co. CA’s holdings in Synopsys were worth $12,875,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Synopsys by 20.7% in the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after acquiring an additional 3,120,401 shares in the last quarter. State Street Corp increased its position in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. Victory Capital Management Inc. raised its stake in Synopsys by 238.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after purchasing an additional 1,990,608 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the last quarter. Finally, Capital Research Global Investors lifted its holdings in Synopsys by 226.6% in the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after purchasing an additional 1,751,432 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Synopsys

In other news, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.56% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on SNPS shares. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Piper Sandler decreased their price target on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company lowered their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 26th. Citigroup began coverage on shares of Synopsys in a research note on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Finally, The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $531.00.

Read Our Latest Research Report on SNPS

Synopsys Stock Down 0.1%

Shares of SNPS opened at $428.67 on Thursday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The stock has a fifty day simple moving average of $457.15 and a two-hundred day simple moving average of $459.91. The company has a market capitalization of $82.12 billion, a PE ratio of 66.56, a price-to-earnings-growth ratio of 3.50 and a beta of 1.15.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. During the same quarter in the previous year, the company posted $3.03 EPS. The company’s revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.